SARS coronavirus 3C-like protease

Also Known As:

3C-like protease, SARS coronavirus; 3C-like protease, severe acute respiratory syndrome coronavirus; 3CL(pro) protein, SARS-CoV; M(pro) protein, SARS-CoV; Nsp5, SARS coronavirus; SARS coronavirus main protease; SARS-CoV main protease

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Chandra, Subhash: 1 article (08/2021)
2.	Joshi, Tanuja: 1 article (08/2021)
3.	Joshi, Tushar: 1 article (08/2021)
4.	Mathpal, Shalini: 1 article (08/2021)
5.	Pundir, Hemlata: 1 article (08/2021)
6.	Sharma, Priyanka: 1 article (08/2021)
7.	Choy, Wai-Yan: 1 article (04/2006)
8.	Chu, Ling-Hon Matthew: 1 article (04/2006)
9.	Ngai, Sai-Ming: 1 article (04/2006)
10.	Rao, Zihe: 1 article (04/2006)

Related Diseases

1.	Severe Acute Respiratory Syndrome 11/30/2004 - "Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease." 05/01/2004 - "Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design." 05/01/2004 - "To accelerate the development of drugs against severe acute respiratory syndrome (SARS), we constructed a homology model of the SARS coronavirus main protease using our modeling software, FAMS Ligand&Complex, and released it before the X-ray structure was solved. " 04/01/2006 - "Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry."
2.	COVID-19 08/01/2021 - "Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19."

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Ligands

Related Therapies and Procedures

1.	Lasers (Laser)